Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Drug Discov Today. 2012 Aug 3;18(1-2):43–49. doi: 10.1016/j.drudis.2012.07.013

Figure 3.

Figure 3

Hypothetical schematic that may account for the tumor-selective toxicity seen with modulators of alternative splicing.

Abbreviation: NMD: nonsense-mediated decay.

HHS Vulnerability Disclosure